FDA Inspection 1021631 — Department AF 81st Med. Group/SGQC Keesler AFB MC Blood Bank

Department AF 81st Med. Group/SGQC Keesler AFB MC Blood Bank — FEI 1077548

The FDA completed an inspection of Department AF 81st Med. Group/SGQC Keesler AFB MC Blood Bank on August 8, 2017 in Keesler Afb, MS. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 8, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Keesler Afb, MS (United States)

Citations

IDCFRDescription
1809721 CFR 630.10(h)Ineligible Donor